Chemical and biological profiling of an annotated compound library directed to the nuclear receptor family

Current Topics in Medicinal Chemistry

Volumn 5, Issue 8, 2005, Pages 763-772

  Cases, Montserrat ^a   García Serna, Ricard ^a   Hettne, Kristina ^b   Weeber, Marc ^c   van der Lei, Johan ^c   Boyer, Scott ^b   Mestres, Jordi ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b ASTRAZENECA R AND D   (Sweden)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR; FARNESOID X RECEPTOR; GLUCOCORTICOID RECEPTOR; LIVER X RECEPTOR; MINERALOCORTICOID RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PREGNANE X RECEPTOR; PROGESTERONE RECEPTOR; RALOXIFENE; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR; VITAMIN RECEPTOR;

BIOINFORMATICS; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG TARGETING; GENE LIBRARY; HIGH THROUGHPUT SCREENING; INFORMATION PROCESSING; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; STRUCTURE ANALYSIS;

COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; LIGANDS; MOLECULAR STRUCTURE; ORGANIC CHEMICALS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 23844456015     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026054637665     Document Type: Review

References (31)

1. Zanders, E. D.; Bailey, D. S.; Dean, p.m. Probes for chemical genomics by design. Drug Discov. Today, 2002, 7, 711-718.
2. Bleicher, K. H.; Böhm, H.-J.; Müller, K.; Alanine, A. I. Hit and lead generation: Beyond high-throughput screening. Nature Rev. Drug Discov., 2003, 2, 369-378.
3. Lee, A.; Breitenbucher, J. G. The impact of combinatorial chemistry on drug discovery. Curr. Opin. Drug Discov. Dev., 2003, 6, 494-508.
4. Gribbon, P.; Andreas, S. High-throughput drug discovery: What can we expect from HTS? Drug Discov. Today, 2005, 10, 17-22.
5. MDL Comprehensive Medicinal Chemistry. MDL Information Systems, Inc.
6. Thomson Derwent World Drug Index. Derwent Information Ltd.
7. MDL Drug Data Report. MDL Information Systems, Inc.
8. Olah, M.; Mracec, M.; Ostopovici, L.; Rad, R.; Bora, A.; Hadaruga, N.; Olah, I.; Banda, M.; Simon, Z.; Oprea, T. I. WOMBAT: World of Molecular Bioactivity. In Chemoinformatics in Drug Discovery. T.I. Oprea (Ed), Wiley-VCH, New York, 2004, pp. 223-239. Sunset Molecular Discovery LLC.
9. Bredel, M.; Jacoby, E. Chemogenomics: An emerging strategy for rapid target and drug discovery. Nature Rev. Genetics, 2004, 5, 262-275.
10. Mestres J. Computational chemogenomics approaches to systematic knowledge-based drug discovery. Curr. Opin. Drug Discov. Dev., 2004, 7, 304-313.
11. Savchuk, N. P.; Balakin, K. V.; Tkachenko, S. E. Exploring the chemogenomic knowledge space with annotated chemical libraries. Curr. Opin. Chem. Biol., 2004, 8, 412-417.
12. Frye, S. V. Structure-activity relationship homology (SARAH): a conceptual framework for drug discovery in the genomic era. Chem. Biol., 1999, 6, R3-R7.
13. Müller, G. Medicinal chemistry of target family-directed masterkeys. Drug Discov. Today, 2003, 8, 681-691.
14. Francis, G. A.; Fayard, E.; Picard, F.; Auwerx, J. Nuclear receptors and the control of metabolism. Annu. Rev. Physiol., 2003, 65, 261-311.
15. Gronemeyer, H.; Gustafsson, J. A.; Laudet, V. Principles for modulation of the nuclear receptor superfamily. Nature Rev. Drug Discov., 2004, 3, 950-964.
16. Schuffenhauer, A.; Zimmermann, J.; Stoop, R.; van der Vyver, J.-J.; Lecchini, S.; Jacoby, E. An ontology for pharmaceutical ligands and its application for in silico screening and library design. J. Chem. Inf. Comput. Sci., 2002, 42, 947-955.
17. Humphrey, P. P. A.; Barnard, E. A. International union of pharmacology. XIX. The IUPHAR Receptor Code: a proposal for an alphanumeric classification system. Pharmacol. Rev., 1998, 50, 271-277.
18. Nuclear Receptors Nomenclature Committee. A unified nomenclature system for the nuclear receptor superfamily. Cell, 1999, 97, 161-163.
19. Xu, Y.-J.; Johnson, M. Using molecular equivalence numbers to visually explore structural features that distinguish chemical libraries. J. Chem. Inf. Comput. Sci., 2002, 42, 912-926.
20. Garriga-Sust, R.; Gregori-Puigjané, E.; Aragües, R.; Johnson, M.; Mestres, J. A. hierarchical classification scheme for chemical structures. Submitted for publication.
21. Bemis, G. W.; Murcko, M. A. The properties of known drugs. I. Molecular frameworks. J. Med. Chem., 1996, 39, 2887-2893.
22. Kauvar, L. M.; Higgins, D. L.; Villar, H. O.; Sportsman, J. R.; Engqvist-Goldstein, A.; Bukar, R.; Bauer, K. E.; Dilley, H.; Rocke, D. M. Predicting ligand binding to proteins by affinity fingerprinting. Chem. Biol., 1995, 2, 107-118.
23. Poulain, R.; Horvath D.; Bonnet, B.; Eckhoff, C.; Chapelain, B.; Bodinier, M.-C.; Déprez, B. From hit to lead. Analyzing structure-profile relationships. J. Med. Chem., 2001, 44, 3391-3401.
24. Merlot, C.; Domine, D.; Cleva, C.; Church, D. J. Chemical substructures in drug discovery. Drug Discov. Today, 2003, 8, 594-602.
25. Rabow, A. A.; Shoemaker, R. H.; Sausville, E. A.; Covell, D. G. Mining the National Cancer Institute's tumor-screening database: Identification of compounds with similar cellular activities. J. Med. Chem., 2002, 45, 818-840.
26. Kunkel, E. J.; Dea, M.; Ebens, A.; Hytopoulos, E.; Melrose, J.; Nguyen, D.; Ota, K. S.; Plavec, I.; Wang, Y.; Watson, S. R.; Butcher, E. C.; Berg, E. L. An integrative biology approach for analysis of drug action in models of human vascular inflammation. FASEB J., 2004, 18, 1279-1281.
27. Giaever, G.; Flaherty, P.; Kumm, J.; Proctor, M.; Nislow, C.; Jaramillo, D. F.; Chu, A. M.; Jordan, M. I.; Arkin, A. P.; Davis, R. W. Chemogenomic profiling: Identifying the functional interactions of small molecules in yeast. Proc. Natl. Acad. Sci. USA, 2004, 101, 793-798.
28. Szakács, G.; Annereau, J.-P.; Lababidi, S.; Shankavaram, U.; Arciello, A.; Bussey, K. J.; Reinhold, W.; Guo, Y.; Kruh, G. D.; Reimers, M.; Weinstein, J. N.; Gottesman, M. M. Predicting drug sensitivity and resistance: Profiling ABC transporter genes in cancer cells. Cancer Cell, 2004, 6, 129-137.
29. Schapira, M.; Abagyan, R.; Totrov, M. Nuclear hormone receptor targeted virtual screening. J. Med. Chem., 2003, 46, 3045-3059.
30. Horvath, D.; Jeandenans, C. Neighborhood behaviour of in silico structural spaces with respect to in vitro activity spaces - A novel understanding of the molecular similarity principle in the context of multiple receptor binding profiles. J. Chem. Inf. Comput. Sci., 2003, 43, 680-690.
31. Paul, N.; Kellenberger, E.; Bret, G.; Müllier, P.; Rognan, D. Recovering the true targets of specific ligands by virtual screening of the Protein Data Bank. Proteins, 2004, 54, 671-680.